Science Explorer Back to mapMap
Discussion
Company · Tarrytown · United States

Progenics Pharmaceuticals (United States)

progenics.comROR OpenAlex
Research works
104
▲ 197% vs 2018-21
Citations
6.2k
59.4 per fractional work
Top-10% rate
13.3%
all institutions 10.0%
Open access
36%
world 40%
International
19%
world 18%
Progenics Pharmaceuticals (United States)

Not ranked overall: Progenics Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Progenics Pharmaceuticals (United States) work in?

In 2022-now, 64% of research at Progenics Pharmaceuticals (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (62%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (16%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 64.5% of its workMedicine: 16 fractional works · 62.4% of its workSurgery: 3 fractional works · 10.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 8.6% of its workOncology: 2 fractional works · 8.0% of its workPhysiology: 2 fractional works · 6.9% of its workHematology: 2 fractional works · 6.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.3% of its workGastroenterology: 1 fractional works · 3.0% of its workPathology and Forensic Medicine: 1 fractional works · 2.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.9% of its workGenetics: 0 fractional works · 1.6% of its workOtorhinolaryngology: 0 fractional works · 1.3% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 1.0% of its workHepatology: 0 fractional works · 0.9% of its workPsychiatry and Mental health: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.8% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.3% of its workUrology: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 2.1% of its workEmergency Medical Services: 1 fractional works · 2.1% of its workLife Sciences: 9 fractional works · 34.0% of its workImmunology and Microbiology: 4 fractional works · 16.9% of its workImmunology: 4 fractional works · 16.9% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 16.0% of its workMolecular Biology: 3 fractional works · 12.6% of its workGenetics: 0 fractional works · 2.0% of its workCancer Research: 0 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workAging: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 1.2% of its workSensory Systems: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.5% of its workSocial Sciences: 0 fractional works · 1.5% of its workSociology and Political Science: 0 fractional works · 1.5% of its workALL ITS WORKProgenicsPharmaceuticals…25fractional works, 2022-now
Life Sciences34%Health Sciences64%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine1662.4%
    2. Health Professions12.1%
    1. Immunology and Microbiology416.9%
    2. Biochemistry, Genetics and Molecular Biology416.0%
    3. Neuroscience01.2%
    1. Social Sciences01.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.00× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 16.78× its world share, 4 worksImmunology and Micro…Neuroscience: 0.71× its world share, 0 worksNeuroscienceHealth Professions: 0.80× its world share, 0 worksHealth ProfessionsMedicine: 3.24× its world share, 16 worksMedicineSocial Sciences: 0.12× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.8×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Immunology and Microbiology16.78×4 works
  2. Medicine3.24×16 works
  3. Biochemistry, Genetics and Molecular Biology3.00×4 works
  4. Health Professions0.80×0 works
  5. Neuroscience0.71×0 works
  6. Social Sciences0.12×0 works

Who are the top researchers at Progenics Pharmaceuticals (United States)?

Ranked on the quality score, Paul Jay Maddon, Nancy Stambler and Jason P. Gardner lead among researchers whose main affiliation is Progenics Pharmaceuticals (United States).

  1. 1 Paul Jay Maddon United States · #93,218 worldwide 15k citations · 67 works
  2. 2 Nancy Stambler United States · #333,497 worldwide 7.8k citations · 120 works
  3. 3 Jason P. Gardner United States · #426,487 worldwide 5k citations · 46 works
  4. 4 Vivien Wong United States · #528,230 worldwide 5.6k citations · 122 works
  5. 5 Yakov Rotshteyn United States · #969,339 worldwide 1.9k citations · 28 works
  6. 6 Tess E. Lin United States · #1,029,487 worldwide 1.2k citations · 26 works
  7. 7 Norbert Schülke United States · #1,130,272 worldwide 1.3k citations · 17 works
  8. 8 Jessica Jensen United States · #1,257,094 worldwide 1.2k citations · 19 works
  9. 9 Gerald P. Donovan United States · #1,574,155 worldwide 1.1k citations · 29 works
  10. 10 Robert J. Durso United States · #1,626,509 worldwide 1.1k citations · 20 works
All ranked researchers at Progenics Pharmaceuticals (United States)

What are the most cited papers from Progenics Pharmaceuticals (United States)?

The most cited paper from Progenics Pharmaceuticals (United States) is "HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5" (Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al., 1996), with 3,221 citations. Next come "CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5" (1,049) and "AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor" (769).

Most cited papers
#PaperReleasedCitations
1 HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al. · Nature 20 Jun 1996 3,221
2 CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Alexandra Trkola, Tatjana Dragic, James A. Arthos et al. · Nature Nov 1996 1,049
3 AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor George A. Donzella, Dominique Schols, Steven Lin et al. · Nature Medicine 1998 769
4 A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield Robert Pejchal et al. · Science Open access 14 Oct 2011 713
5 Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia Tino Schenk, Weihsu Claire Chen, Stefanie Göllner et al. · Nature Medicine Open access 11 Mar 2012 671
All 60 most cited papers, with filters and sorting

Which keywords describe research at Progenics Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Treatment, Diagnosis, Epidemiology, Management, Inflammatory Diseases, Regulatory T Cells and IL-33.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Inflammation6▲ 10×12 topics
  2. Epidemiology4▲ 4.2×10 topics
  3. Treatment4▲ 12×5 topics
  4. Diagnosis3▲ 14×8 topics
  5. Inflammatory Diseases3▲ 66×3 topics
  6. Management3▲ 16×5 topics
  7. IL-333▲ 632×1 topic
  8. Innate Lymphoid Cells3▲ 632×1 topic
  9. Regulatory T Cells3▲ 107×3 topics
  10. Children2▲ 36×2 topics
  11. Guidelines2▲ 17×2 topics
  12. Adults2▲ 139×1 topic
  13. Eosinophilic Esophagitis2▲ 320×1 topic
  14. Asthma2▲ 77×2 topics
  15. Immune Response2▲ 13×5 topics
  16. Allergic Diseases2▲ 111×1 topic
  17. Eosinophils2▲ 111×1 topic
  18. Genetics2▲ 9.3×2 topics
  19. Cell Death1▲ 22×2 topics
  20. Inflammasome1▲ 129×1 topic
  21. Lymphoma1▲ 32×2 topics
  22. NLRP31▲ 129×1 topic
  23. Hematopoietic Stem Cells1▲ 54×3 topics
  24. Immunotherapy1▲ 6.1×2 topics
  25. Tumor Microenvironment1▲ 9.4×4 topics

Which research topics does Progenics Pharmaceuticals (United States) publish most on?

By volume in 2022-now: IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Asthma and respiratory diseases and Inflammasome and immune disorders.

IL-33, ST2, and ILC Path…3IL-33, ST2, and ILC Pathways: 3 fractional worksEosinophilic Esophagitis: 2 fractional worksAsthma and respiratory diseases: 2 fractional worksInflammasome and immune …1Inflammasome and immune disorders: 1 fractional worksChronic Obstructive Pulm…1Chronic Obstructive Pulmonary Disease (COPD) Research: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksHematopoietic Stem Cell Transplantation: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksRNA modifications and cancer: 1 fractional works
ImmunologySurgeryPhysiologyMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 IL-33, ST2, and ILC Pathways Immunology 3 works
  2. 2 Eosinophilic Esophagitis Surgery 2 works
  3. 3 Asthma and respiratory diseases Physiology 2 works
  4. 4 Inflammasome and immune disorders Molecular Biology 1 works
  5. 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 Hematopoietic Stem Cell Transplantation Hematology 1 works
  9. 9 T-cell and B-cell Immunology Immunology 1 works
  10. 10 RNA modifications and cancer Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.1%not open63.9%

World: 40% of research is openly available.

with international co-authors19.1%domestic only80.9%

World: 18% is written across borders.

How has Progenics Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 197% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Progenics Pharmaceuticals (United States) as a percentage of every work published that year, 0.00016% in 2024.

still counting0.00010%0.00020%0.00030%Progenics Pharmaceuticals (United States)0.00017% in 20251990200020102020

Fractional works of Progenics Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tarrytown

All research institutions in Tarrytown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Progenics Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.